Yet, the blast cells of these patients had rearrangements similar to Ph+ ALL such as CRLF2 rearrangements, a JAK mutation or a variety of additional kinase alterations (ABL1, JAK2, PDGFRB, EPOR, IL7R, SH2B3, FLT3 etc.). This evidence concerns the gene ABL1 and acute lymphoblastic leukemia.